SANATELA

OUR BUSINESSES

ATVC is a venture building company that provides advanced technologies that are light years ahead of its competition. Located in the center of Western New York, ATVC is the parent accelerating company that provides executive leadership to commercialize the technology of these early stage companies. They are listed below with links connecting to their individual pages.

SANATELA™:

PRECISION
CANCER

SANATELA™:

REGENETIVE

MEDICINE

SANATELA™:

BIOTECH-

NOLOGIES

Cancer is a stem cell disease. Our precision medicine technology is a lab developed test that determines how your cancer stem cells respond to chemotherapy before undergoing treatment.

Built on a foundation of innovation, developing, producing, and selling regenerative solutions for skin (wounds and burns) and bone fractures. SRM's Wharton's jelly scaffold encourages the body to bio-attract stem cells to the point of injury.

Veterinarians are leaning more and more in applying our technical knowledge and regenerative knowledge to care for animals.

SANATELA™:

ANIMAL

HEALTH

Biotechnological solutions utilizing innovative techniques and methods to provide care.

REGENERELLE™

HARRAGAN™

Expand your cell and stem

cell culture experience with SanatelaMatrix(TM) -natural extracellular matrix. Shelf Stable. No Thaw. Room temperature stable. Excellent lot-to-lot consistency. Ready to ship immediately. 3D Cell Cultures assays. Natural ready to use. Human Wharton's jelly Bio-based product. No

animal base.

SANATELA™:

LIFE

SCIENCES

Optimizing nanoparticle biotechnology, RESILIÉLLE has dedicated years of research to develop innovative, all natural products that use Age-Zero topical cosmetic exosomes to deliver the most potent cosmetic products on the market.

RESILIÉLLE™

Harragan is a company focused on commercializing innovative research leading to the development of high-value products for large-market opportunities. Our clinical strengths are in addressing hair regeneration.

Experts in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry leading quality, we make MSCs easier to access and much simpler to incorporate into product development efforts, leading to rapid acceleration in products coming to market that incorporate these technologies.